Research & Development
Policy & Regulation
Trends & Finance
Enzo launches RNA gene expression platform for HPV
The platform's products combine sequence-specific probes with Enzo's LoopRNA in situ hybridization (ISH) technology, enabling the products to detect target genes in tissue or cell samples while preserving the morphology, Enzo said. This study of single cells within their native tissue environment, called spatial biology, helps scientists characterize and understand disease, Enzo added.
September 25, 2022
Glucose testing market to reach $27.1B by 2027: Kalorama
With a compound annual growth rate (CAGR) anticipated at 5.9%, the market is expected to reach $27.1 billion by 2027, said the report published by LabPulse.com's sister brand Kalorama Information.
September 18, 2022
Precipio announces agreement to promote HemeScreen platform
The distributor focuses on a segment of the healthcare business which by Precipio's estimates represents an additional $100 million of market potential that its current distributors are less likely to reach.
September 15, 2022
Ibex announces study results for breast pathology platform
Ibex chief medical officer Dr. Judith Sandbank reported at the congress 100% sensitivity and specificity for pathologists diagnosing breast cancer using the platform.
September 8, 2022
Freenome launches study of multiomics cancer platform
The Sanderson Study will generate evidence of clinical validation for certain high- and elevated-risk populations while refining the platform's cancer classification and risk prediction models, the South San Francisco-based firm said.
September 5, 2022
Bruker launches new nano-LC chromatography platform
The platform includes MetaboScape and TASQ 2023 software to support fluxomics, as well as the PaSER database search platform's tools for research in protein-protein interactions and metaproteomics applications, the company said.
August 28, 2022
Quest launches long-COVID testing panels for consumers
Ohio, Kentucky doctors convicted in scheme to bill Medicaid for millions of dollars in unnecessary urinalysis testing
RNA-seq analysis links protein to spread of pancreatic cancer, reveals potential drug target
Patients prefer immediate test results, even when the news is bad
Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux
Quest Diagnostics offers suite of services for transplant patients and living donors
Boosted by COVID-19 and cancer tests, IVD market reaches $127B: Kalorama
That's the finding from Kalorama's market research report, The Worldwide Market for In Vitro Diagnostics, 15th edition.
August 25, 2022
Mainz Biomed, Dante Genomics expand ColoAlert availability
ColoAlert, Mainz Biomed's flagship product, will be marketed through Dante's database and sold through its region-specific e-commerce websites.
August 15, 2022
OraSure Technologies Q2 revenues rise on COVID testing
For the quarter ended June 30, the Bethlehem, PA-based company reported revenues of $80.2 million compared to $57.2 million in Q2 2021, beating analysts' average estimate of $70.1 million.
August 8, 2022
Video from AACC: BrightInsight's Connected Diagnostics Platform
Dr. Kal Patel, CEO and co-founder, and Andrea Curtis, director of in vitro diagnostics product management, sat down with ScienceBoard.net's sister site LabPulse.com to discuss how the platform enables greater product innovation, new revenue streams, and streamlined workflows.
July 27, 2022
BrightInsight launches digital diagnostics platform at AACC
The platform consists of four tools -- Proxy Agent, Analytics Dashboards, Integration Middleware, and Workflow Portals -- for the IVD manufacturer and the lab, providing an end-to-end platform that streamlines workflows, according to BrightInsight.
July 24, 2022
Companies announce new products ahead of AACC 2022
Among them, OraSure Technologies said that its Omnigene Gut DNA and RNA product is available to gut microbiome researchers. The product, made by OraSure subsidiary DNA Genotek, allows for self-collection, stabilization, storage, and transportation of both microbial DNA and RNA at ambient temperature for gut microbiome profiling.
July 21, 2022
Page 1 of 8